Insecticides India Share Price Target 2027
- November 17, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Insecticides India share price Rs 540.60 (17 November 2026). Base target Rs 641, bull Rs 775, downside risk Rs 436. PE 12.97. 52W range Rs 500.00 to Rs 775.00.
Quick Answer
The Insecticides India share price target for 2027 is Rs 641, about 18.6% above the current price of Rs 540.60. The bull case is Rs 775, and the downside risk level, which is not a target, is Rs 436. The base case assumes earnings per share grow 17.7% a year, the pace seen from FY24 to FY26, with the stock holding its PE of 12.97. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Insecticides India target price for 2027 should start with where the stock sits today. At Rs 540.60 on 17 November 2026, it is 30.2% below its 52-week high of Rs 775.00 and 8.1% above its 52-week low of Rs 500.00. That range spans 55% from low to high, so the entry point matters as much as the Insecticides India price forecast itself.
This article builds the Insecticides India share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.
Click Here – Get Free Investment Predictions
Insecticides India Stock Analysis: Company Overview and Key Stats
Insecticides India (NSE: INSECTICID) has a market capitalisation of Rs 1,586 crore. In FY26 it reported revenue of Rs 2,152 crore and net profit of Rs 139.41 crore. The table collects the figures the Insecticides India share price target is built on.
| Metric | Value |
|---|---|
| Company | Insecticides India |
| NSE Ticker | INSECTICID |
| CMP (17 November 2026) | Rs 540.60 |
| 52-Week High | Rs 775.00 |
| 52-Week Low | Rs 500.00 |
| Market Cap | Rs 1,586 crore |
| PE Ratio (TTM) | 12.97 |
| Industry PE | 22.94 |
| Price to Book | 1.20 |
| Return on Equity | 9.26% |
| Debt to Equity | 0.19 |
| EPS (TTM) | Rs 42.01 |
| Dividend Yield | 0.37% |
| 12-Month Base Target | Rs 641 |
| Bull Case | Rs 775 |
| Downside Risk Level (not a target) | Rs 436 |
Why Is Insecticides India Share Price Target Set at Rs 641 for 2027?
The arithmetic is short. Trailing EPS of Rs 42.01 grown for one year gives a forward EPS estimate of Rs 49.44, and multiplying it by the unchanged PE of 12.97 gives the Rs 641 base-case Insecticides India stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Insecticides India Target Price: Five Years of Results
Insecticides India grew revenue from Rs 1,508 crore in FY22 to Rs 2,152 crore in FY26, a compound annual growth rate of 9.3%. Net profit grew more slowly, from Rs 107.43 crore to Rs 139.41 crore (6.7% a year), which points to margin pressure alongside the sales growth.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 1,508.23 | 107.43 | 54.17 | 3.00 |
| FY23 | 1,802.59 | 63.21 | 21.36 | 3.00 |
| FY24 | 1,975.85 | 102.37 | 34.59 | 3.00 |
| FY25 | 2,006.95 | 142.02 | 48.38 | 2.00 |
| FY26 | 2,151.72 | 139.41 | 47.91 | 2.00 |
FY26 revenue growth was 7.2%, slower than the four-year average of 9.3%, and net profit moved down 1.8%. EPS rose from Rs 34.59 in FY24 to Rs 47.91 in FY26. The FY27 outlook for the Insecticides India price target depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Insecticides India converted 6.5% of FY26 revenue into net profit, against 7.1% in FY25, within a five-year range of 3.5% to 7.1%. EBITDA margin was 11.1% in FY26 versus 11.4% in FY25.
In the September 2026 quarter, revenue was Rs 685.47 crore, up 7.1% from the same quarter a year earlier, while net profit of Rs 56.17 crore was down 5.0%. EBITDA came in at Rs 91.60 crore, down 0.4% year on year. The next quarterly result is the first test of whether the earnings assumption behind the Insecticides India stock target holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.19, and shareholders’ equity grew from Rs 869.61 crore in FY22 to Rs 1,220 crore in FY26. Operating cash flow in FY26 was Rs 100.25 crore against capital expenditure of Rs 94.59 crore, leaving free cash flow of Rs 5.66 crore, or 0.4% of the current market capitalisation. In FY25 free cash flow was Rs 56.17 crore.
Valuation Check for the Insecticides India Stock Target: PE, Price to Book and ROE
At a PE of 12.97 against an industry PE of 22.94, Insecticides India trades at a discount to its industry. Price to book is 1.20 on a book value of Rs 453.72 per share, and return on equity is 9.26%. A PE of 12.97 equals an earnings yield of 7.7%, and the FY26 dividend of Rs 2.00 per share gives a yield of 0.37%.
Shareholding Pattern and Institutional Holding
Promoters held 72.30% of Insecticides India in September 2026, and promoter holding has stayed near 72.30% since September 2025. Foreign institutional investors (FII) held 4.44% and domestic institutions (DII) held 9.26%, which puts total institutional holding at 13.70%. FII holding has stayed near 4.44% since September 2025. Public shareholders own the remaining 14.00%.
Insecticides India Share Price Targets for the Short Term and 12 Months
Short Term Insecticides India Stock Target Levels: Technical Setup
At Rs 540.60 on 17 November 2026, Insecticides India trades below its 50-day simple moving average of Rs 572.58 and below its 200-day exponential moving average of Rs 631.10. The 14-day RSI reads 63.0, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 572.58 (50-day simple moving average) and the nearest support is Rs 500.00 (52-week low). A sustained move above Rs 572.58 would improve the short-term setup, while a close below Rs 500.00 would shift attention to the next support.
12 Month Insecticides India Target Price for 2027
The 12-month target of Rs 641 means a move of 18.6% up from Rs 540.60 over the next 12 months. It would still leave the stock 17.3% below its 52-week high of Rs 775.00. Anyone checking the Insecticides India share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.
How EPS Growth and PE Multiple Change the Insecticides India Target Price
| EPS Growth | PE 10.38 | PE 12.97 | PE 14.92 |
|---|---|---|---|
| 0.0% (EPS Rs 42.01) | Rs 436 | Rs 545 | Rs 627 |
| 17.7% (EPS Rs 49.44) | Rs 513 | Rs 641 | Rs 738 |
| 23.7% (EPS Rs 51.96) | Rs 539 | Rs 674 | Rs 775 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Insecticides India price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Insecticides India Stock Target in 2027
Bull Case Rs 775
The bull case Insecticides India price target needs EPS growth of 23.7%, which lifts forward EPS to Rs 51.96, and a PE multiple that rises 15% to 14.92. That gives Rs 775, 43.4% above the current price and below the 52-week high of Rs 775.00.
Downside Risk Level Rs 436
The downside risk level is not a target. It assumes EPS stays flat at Rs 42.01 and the PE falls 20% to 10.38. That gives Rs 436, 19.3% below the current price and below the 52-week low of Rs 500.00.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 23.7% | 14.92 | Rs 775 | +43.4% |
| Base Case | 17.7% | 12.97 | Rs 641 | +18.6% |
| Downside Risk | 0.0% | 10.38 | Rs 436 | -19.3% |
Key Risks to the Insecticides India Target Price for 2027
Growth Slowdown Risk for the Insecticides India Price Target
Revenue in the September 2026 quarter was up 7.1% year on year, and FY26 revenue growth was 7.2%. If growth slows from here, the EPS estimate behind the Insecticides India stock target will need revising.
Liquidity and Size Risk
Insecticides India has a market capitalisation of Rs 1,586 crore. Institutional holding is 13.70%, and promoters hold 72.30%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 6.5% in FY26, so a small slip in costs moves profit noticeably. At a PE of 12.97 versus an industry PE of 22.94, a de-rating toward the downside-risk PE of 10.38 would cut the price even if earnings hold.
Market and Technical Risk
Technical indicators add short-term risk: the 14-day RSI is 63.0 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time. That applies to any Insecticides India stock target, however carefully it is built.
How to Invest in Insecticides India
Start with the live price and volume. Any Insecticides India share price target is only as current as the data behind it, and the data here is as of 17 November 2026, so refresh the Rs 540.60 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Insecticides India’s PE, ROE, debt and shareholding in one place.
Check Insecticides India fundamentals on the Univest Screener
Then compare the three Insecticides India target price scenarios with your own view. If you expect EPS growth below 17.7%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Insecticides India live price and get daily stock recommendations.
Conclusion
The Insecticides India share price target for 2027 is Rs 641 in the base case, with Rs 775 as the bull case. The support for that view is arithmetic you can check: EPS grew 17.7% a year over FY24 to FY26, and the stock trades at a PE of 12.97. The risks are equally concrete, including a net margin of just 6.5% that leaves profit sensitive to costs and a downside scenario that cuts the price 19% if earnings stall. Use these numbers as a framework for judging the Insecticides India price target, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Insecticides India Share Price Target 2027
What is the Insecticides India share price target for 2027?
Ans. The base-case Insecticides India share price target for 2027 is Rs 641, which is 18.6% above the price of Rs 540.60 on 17 November 2026. The bull case is Rs 775 and the downside risk level, which is not a target, is Rs 436. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.
What is the Insecticides India share price today?
Ans. As of 17 November 2026, before market open, Insecticides India (NSE: INSECTICID) is quoted at Rs 540.60, which is its last closing price from the previous session. That is 30.2% below the 52-week high of Rs 775.00 and 8.1% above the 52-week low of Rs 500.00. The market capitalisation of Rs 1,586 crore places it among small-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.
Is Insecticides India a buy or sell at the current price?
Ans. The data points both ways. On the positive side, EPS has grown 17.7% a year over FY24 to FY26 and the base case implies 18.6% upside; on the cautious side, the net margin is a thin 6.5%, and the downside risk level of Rs 436 is 19% below the current price. Whether Insecticides India fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.
What are the bull case target and downside risk level for Insecticides India shares?
Ans. The bull case in the Insecticides India share price target for 2027 is Rs 775, which assumes 23.7% EPS growth and a PE of 14.92, a 15% re-rating from today’s multiple. That is 43.4% above the current price and below the 52-week high of Rs 775.00. The downside risk level is Rs 436, which assumes flat EPS and a PE of 10.38, 20% lower than today. It sits 19.3% below the current price and below the 52-week low of Rs 500.00, and it marks a risk to watch, not a target.
What are the main risks to the Insecticides India price target?
Ans. Four risks matter most for the Insecticides India share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 1,586 crore, the stock can move sharply on small volumes, and exits can take longer than entries. A fall to the downside-risk PE of 10.38 would cut the price even if earnings hold.
What is the PE ratio of Insecticides India and how does it compare with the industry?
Ans. The PE ratio of Insecticides India is 12.97, against an industry PE of 22.94, which is a discount to the industry. Price to book is 1.20 and return on equity is 9.26%, and the PE equals an earnings yield of 7.7%. The base case holds the PE unchanged, so the Insecticides India share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.
Who owns Insecticides India, and what is the promoter holding?
Ans. Promoters held 72.30% of Insecticides India in September 2026. FII held 4.44%, DII held 9.26% and the public held 14.00%. Together the two institutional groups hold 13.70%. Shareholding is filed every quarter, so it is worth rechecking after each result.
What were Insecticides India’s latest quarterly results?
Ans. In the September 2026 quarter, Insecticides India reported revenue of Rs 685.47 crore (up 7.1% year on year) and net profit of Rs 56.17 crore (down 5.0%). For comparison, FY26 full-year revenue growth was 7.2% and net profit moved down 1.8%. Each new quarter either supports or weakens the EPS growth of 17.7% assumed in the base case.